SKI 2670

Drug Profile

SKI 2670

Alternative Names: SKI2670

Latest Information Update: 02 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator SK Chemicals
  • Class
  • Mechanism of Action Gonadotropin releasing hormone inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Uterine diseases

Most Recent Events

  • 01 Aug 2016 SK Chemicals completes a phase I trial in Uterine disorders (in volunteers) in South Korea (PO) (NCT02202408)
  • 08 Apr 2016 Phase-I development is ongoing in South Korea
  • 01 Jul 2014 Phase-I clinical trials in Uterine disorders (in volunteers) in South Korea (PO) (NCT02202408)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top